Clinical Trial Detail

NCT ID NCT01935947
Title Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

Therapies

Gemcitabine

Azacitidine + Entinostat

Docetaxel + Irinotecan + Pemetrexed Disodium

Age Groups: adult

No variant requirements are available.